Tolcher, Anthony
NEXT Oncology,
United States
2023 Rank: 24849
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Pharmacology & Pharmacy
Rank in SubField 1: 1130 out of 312644 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 24849 | 30358 |
| Total Cites | 15567 | 16464 |
| H-index | 63 | 64 |
| Hm-index | 18 | 18 |
| Number of Single Authored Papers | 14 | 14 |
| Total Cites to Single Authored Papers | 290 | 291 |
| Number of Single+First Authored Papers | 56 | 56 |
| Total Cites to Single+First Authored Papers | 3710 | 3839 |
| Number of Single+First+Last Authored Papers | 101 | 101 |
| Total Cites to Single+First+Last Authored Papers | 6796 | 7119 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 13835 | 14489 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.14 |
| Self-Citation Percentage |
5.45%
|
|
Tolcher, Anthony
South Texas Accelerated Research Therapeutics (START),
United States
2021 Rank: 25375
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Oncology & Carcinogenesis
SubField 2:
Urology & Nephrology
Rank in SubField 1: 1165 out of 271773 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 25375 | 29493 |
| Total Cites | 13535 | 14358 |
| H-index | 58 | 59 |
| Hm-index | 17 | 18 |
| Number of Single Authored Papers | 13 | 13 |
| Total Cites to Single Authored Papers | 262 | 263 |
| Number of Single+First Authored Papers | 55 | 55 |
| Total Cites to Single+First Authored Papers | 3285 | 3405 |
| Number of Single+First+Last Authored Papers | 96 | 96 |
| Total Cites to Single+First+Last Authored Papers | 5740 | 6012 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 12021 | 12618 |
| Ratio of Total Citations to Distinct Citing Papers | 1.13 | 1.14 |
| Self-Citation Percentage |
5.73%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.